Healthcare & Life Sciences
Connect Biopharma
United Stateswww.connectbiopharma.com/
Connect Biopharma is a series c plus startup based in United States. 1 investor tracked.
Activeseries-c-plus
series-c-plus
Stage
3
Investors
About Connect Biopharma
Based in the United States, Connect Biopharma is a startup. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
Connect Biopharma is a clinical-stage biopharmaceutical company developing next-generation therapeutics for inflammatory respiratory diseases such as asthma and COPD, currently conducting global Phase 2 trials for their lead candidate rademikibart (CBP-201).
Explore Connect Biopharma's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.